JP2017507145A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017507145A5 JP2017507145A5 JP2016553402A JP2016553402A JP2017507145A5 JP 2017507145 A5 JP2017507145 A5 JP 2017507145A5 JP 2016553402 A JP2016553402 A JP 2016553402A JP 2016553402 A JP2016553402 A JP 2016553402A JP 2017507145 A5 JP2017507145 A5 JP 2017507145A5
- Authority
- JP
- Japan
- Prior art keywords
- delivery system
- substance delivery
- matrix
- polymeric material
- anabolic agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000126 substance Substances 0.000 claims 12
- 239000011159 matrix material Substances 0.000 claims 7
- 239000000463 material Substances 0.000 claims 6
- 229940124325 anabolic agent Drugs 0.000 claims 5
- 239000003263 anabolic agent Substances 0.000 claims 5
- 102000003977 fibroblast growth factor 18 Human genes 0.000 claims 3
- 108090000370 fibroblast growth factor 18 Proteins 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 102000008186 Collagen Human genes 0.000 claims 2
- 108010035532 Collagen Proteins 0.000 claims 2
- 229920002683 Glycosaminoglycan Polymers 0.000 claims 2
- 230000002051 biphasic effect Effects 0.000 claims 2
- 208000015100 cartilage disease Diseases 0.000 claims 2
- 230000002648 chondrogenic effect Effects 0.000 claims 2
- 229920001436 collagen Polymers 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 238000002513 implantation Methods 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 206010007710 Cartilage injury Diseases 0.000 claims 1
- 206010061762 Chondropathy Diseases 0.000 claims 1
- 201000009859 Osteochondrosis Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14000598 | 2014-02-20 | ||
| EP14000598.4 | 2014-02-20 | ||
| PCT/EP2015/053645 WO2015124739A1 (en) | 2014-02-20 | 2015-02-20 | Implant comprising fgf-18 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017507145A JP2017507145A (ja) | 2017-03-16 |
| JP2017507145A5 true JP2017507145A5 (Direct) | 2018-02-22 |
| JP6510547B2 JP6510547B2 (ja) | 2019-05-08 |
Family
ID=50151086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016553402A Active JP6510547B2 (ja) | 2014-02-20 | 2015-02-20 | Ｆｇｆ−１８を含むインプラント |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US10086112B2 (Direct) |
| EP (1) | EP3107592B1 (Direct) |
| JP (1) | JP6510547B2 (Direct) |
| KR (1) | KR102421950B1 (Direct) |
| CN (1) | CN106232154A (Direct) |
| AR (1) | AR099556A1 (Direct) |
| AU (1) | AU2015220785B2 (Direct) |
| BR (1) | BR112016018681B1 (Direct) |
| CA (1) | CA2938796C (Direct) |
| DK (1) | DK3107592T3 (Direct) |
| ES (1) | ES2698117T3 (Direct) |
| HR (1) | HRP20181573T1 (Direct) |
| IL (1) | IL247106B (Direct) |
| LT (1) | LT3107592T (Direct) |
| MX (1) | MX368946B (Direct) |
| NZ (1) | NZ723177A (Direct) |
| PL (1) | PL3107592T3 (Direct) |
| PT (1) | PT3107592T (Direct) |
| RS (1) | RS58138B1 (Direct) |
| RU (1) | RU2700414C2 (Direct) |
| SG (1) | SG11201606697YA (Direct) |
| SI (1) | SI3107592T1 (Direct) |
| WO (1) | WO2015124739A1 (Direct) |
| ZA (1) | ZA201605667B (Direct) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2684527T3 (es) | 2013-02-14 | 2018-10-03 | Nanopareil, Llc | Fieltro híbrido de nanofibras electrohiladas, método de preparación del mismo y método de purificación de biomoléculas |
| CA2938791A1 (en) | 2014-02-20 | 2015-08-27 | Merck Patent Gmbh | Fgf-18 compound dosing regimen |
| AU2016211950A1 (en) | 2015-01-29 | 2017-07-13 | Ares Trading S.A. | Immunoassays for high positively charged proteins |
| HUE058786T2 (hu) | 2017-09-29 | 2022-09-28 | Merck Patent Gmbh | FGF-18 vegyületre vonatkozó válaszkészség elõrejelzésére szolgáló metabolikus biomarkerek |
| DK3688468T3 (da) | 2017-09-29 | 2022-06-20 | Merck Patent Gmbh | Inflammatoriske biomarkører til forudsigelse af modtageligheden for fgf-18 forbindelse |
| IL281333B2 (en) | 2018-09-10 | 2025-11-01 | Merck Patent Gmbh | A method for reducing risk in a clinical trial |
| CN117187255B (zh) * | 2023-11-07 | 2024-01-30 | 北京大学第三医院（北京大学第三临床医学院） | 编码FGF18或rhFGF18的mRNA及其在骨关节炎治疗中的应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6511958B1 (en) * | 1997-08-14 | 2003-01-28 | Sulzer Biologics, Inc. | Compositions for regeneration and repair of cartilage lesions |
| ATE220564T1 (de) * | 1997-08-14 | 2002-08-15 | Sulzer Innotec Ag | Zusammensetzung und vorrichtung zur reparatur von knorpelgewebe in vivo bestehend aus nanokapseln mit osteoinduktiven und/oder chondroinduktiven faktoren |
| KR100380119B1 (ko) * | 2001-04-19 | 2003-04-11 | 한국항공우주연구원 | 이원화된 통신속도 적응형 베이스 밴드 스위칭 위상시프트 키잉 장치 |
| EP1273365A1 (fr) * | 2001-07-06 | 2003-01-08 | Recherche Et Developpement Du Groupe Cockerill Sambre | Outils rotatifs pour le perçage en ligne de produits profiles |
| AU2003279835B2 (en) * | 2002-10-07 | 2009-09-10 | Zymogenetics, Inc. | Methods of administering FGF18 |
| US8852240B2 (en) * | 2004-10-25 | 2014-10-07 | Kieran Murphy, Llc | Methods and compositions for fostering and preserving bone growth |
| SI1828239T1 (sl) * | 2004-12-10 | 2011-11-30 | Zymogenetics Inc | Proizvodnja fgf18 v prokariotskih gostiteljih |
| CN101505787B (zh) * | 2006-08-25 | 2013-09-04 | 阿雷斯贸易股份有限公司 | 软骨障碍的治疗 |
| JP2012519556A (ja) * | 2009-03-05 | 2012-08-30 | バイオミメティック セラピューティクス， インコーポレイテッド | 骨軟骨欠損を治療するための血小板由来増殖因子組成物および方法 |
| US8431399B2 (en) * | 2010-03-02 | 2013-04-30 | Taipei Medical University | Method to restore cartilaginous phenotype of chondrocytes after cultured and expanded in vitro |
| WO2012094511A2 (en) * | 2011-01-05 | 2012-07-12 | Rhode Island Hospital | Compositions and methods for the treatment of orthopedic disease or injury |
| EP2678048B1 (en) * | 2011-02-22 | 2018-11-21 | Institut National de la Sante et de la Recherche Medicale (INSERM) | Nano-reservoirs technology for use in bone and/or cartilage regeneration |
| EP3086822B1 (en) * | 2013-12-24 | 2020-04-15 | Ares Trading SA | Fgf-18 formulation in alginate/collagen hydrogels |
| EP3107591B1 (en) | 2014-02-20 | 2018-04-18 | Merck Patent GmbH | Fgf-18 in graft transplantation and tissue engineering procedures |
| CA2938791A1 (en) | 2014-02-20 | 2015-08-27 | Merck Patent Gmbh | Fgf-18 compound dosing regimen |
-
2015
- 2015-02-20 US US15/120,137 patent/US10086112B2/en active Active
- 2015-02-20 EP EP15706011.2A patent/EP3107592B1/en active Active
- 2015-02-20 CN CN201580020527.3A patent/CN106232154A/zh active Pending
- 2015-02-20 LT LTEP15706011.2T patent/LT3107592T/lt unknown
- 2015-02-20 HR HRP20181573TT patent/HRP20181573T1/hr unknown
- 2015-02-20 AU AU2015220785A patent/AU2015220785B2/en active Active
- 2015-02-20 PT PT15706011T patent/PT3107592T/pt unknown
- 2015-02-20 KR KR1020167025247A patent/KR102421950B1/ko active Active
- 2015-02-20 PL PL15706011T patent/PL3107592T3/pl unknown
- 2015-02-20 RU RU2016137291A patent/RU2700414C2/ru active
- 2015-02-20 SG SG11201606697YA patent/SG11201606697YA/en unknown
- 2015-02-20 NZ NZ723177A patent/NZ723177A/en unknown
- 2015-02-20 JP JP2016553402A patent/JP6510547B2/ja active Active
- 2015-02-20 WO PCT/EP2015/053645 patent/WO2015124739A1/en not_active Ceased
- 2015-02-20 SI SI201530409T patent/SI3107592T1/sl unknown
- 2015-02-20 BR BR112016018681-8A patent/BR112016018681B1/pt active IP Right Grant
- 2015-02-20 AR ARP150100505A patent/AR099556A1/es not_active Application Discontinuation
- 2015-02-20 ES ES15706011T patent/ES2698117T3/es active Active
- 2015-02-20 RS RS20181404A patent/RS58138B1/sr unknown
- 2015-02-20 DK DK15706011.2T patent/DK3107592T3/en active
- 2015-02-20 CA CA2938796A patent/CA2938796C/en active Active
- 2015-02-20 MX MX2016010874A patent/MX368946B/es active IP Right Grant
-
2016
- 2016-08-04 IL IL247106A patent/IL247106B/en active IP Right Grant
- 2016-08-16 ZA ZA2016/05667A patent/ZA201605667B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017507145A5 (Direct) | ||
| Haggerty et al. | Biomaterials for revascularization and immunomodulation after spinal cord injury | |
| RU2016137291A (ru) | Имплантат, содержащий fgf-18 | |
| JP2014139220A5 (Direct) | ||
| MX384527B (es) | Compuestos derivados de oxadiazolamina como inhibidores de histona desacetilasa 6, y la composición farmacéutica que comprende los mismos | |
| MY194018A (en) | 1,3,4-oxadiazole sulfamide derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical composition comprising the same | |
| JP2017512194A5 (Direct) | ||
| JP2016517888A5 (Direct) | ||
| JP2017501140A5 (Direct) | ||
| JP2017507142A5 (Direct) | ||
| SG10201903210WA (en) | Sunitinib Formulations and Methods for Use Thereof in Treatment of Ocular Disorders | |
| JP2017522288A5 (Direct) | ||
| RU2016137292A (ru) | Схема применения соединения fgf-18 | |
| JP2011225596A5 (Direct) | ||
| WO2021034958A3 (en) | Materials for delivery of tetherable proteins in bone implants | |
| JP2017513809A5 (Direct) | ||
| JP2017105862A5 (Direct) | ||
| JP2018521643A5 (Direct) | ||
| JP2017105859A5 (Direct) | ||
| HRP20180061T1 (hr) | Indolkarbonitrili kao selektivni modulatori androgenskih receptora | |
| NZ729628A (en) | Methods for the treatment of peri-implantitis | |
| JP2016515517A5 (Direct) | ||
| EP4470625A3 (en) | A pharmaceutical composition comprising a combination of probiotic and prebiotic to treat stunting | |
| JP2017502058A5 (Direct) | ||
| JP2015512923A5 (Direct) |